Avity Investment Management Inc. Abb Vie Inc. Transaction History

Avity Investment Management Inc.

$1.25 Billion
Q3 2024

A detailed history of Avity Investment Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Avity Investment Management Inc. holds 3,179 shares of ABBV stock, worth $558,168. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,179

Previous 3,443 7.67%

Holding current value

$558,168

Previous $590,000 6.27%

% of portfolio

0.05%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$163.84 - $199.33 $43,253 - $52,623	-264 Reduced 7.67%	3,179 $627,000
Q2 2024 Jul 11, 2024	SELL	$154.79 - $180.76 $773 - $903	-5 Reduced 0.15%	3,443 $590,000
Q1 2024 Apr 16, 2024	BUY	$159.82 - $182.1 $27,169 - $30,957	170 Added 5.19%	3,448 $627,000
Q3 2023 Oct 18, 2023	SELL	$133.59 - $154.65 $26,718 - $30,930	-200 Reduced 5.75%	3,278 $488,000
Q2 2023 Jul 17, 2023	SELL	$132.51 - $164.9 $159,409 - $198,374	-1,203 Reduced 25.7%	3,478 $468,000
Q1 2023 Apr 18, 2023	SELL	$144.61 - $166.54 $35,429 - $40,802	-245 Reduced 4.97%	4,681 $746,000
Q4 2022 Jan 12, 2023	SELL	$138.31 - $165.87 $27,662 - $33,174	-200 Reduced 3.9%	4,926 $796,000
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $73,815 - $84,661	550 Added 12.02%	5,126 $688,000
Q2 2022 Jul 13, 2022	BUY	$137.62 - $174.96 $68,810 - $87,480	500 Added 12.27%	4,576 $701,000
Q2 2021 Jul 13, 2021	SELL	$105.21 - $117.21 $15,045 - $16,761	-143 Reduced 3.39%	4,076 $459,000
Q4 2020 Jan 15, 2021	SELL	$80.49 - $108.67 $29,942 - $40,425	-372 Reduced 8.1%	4,219 $452,000
Q2 2020 Jul 15, 2020	BUY	$73.37 - $98.18 $220 - $294	3 Added 0.07%	4,591 $451,000
Q1 2020 Apr 09, 2020	SELL	$64.5 - $97.79 $51,600 - $78,232	-800 Reduced 14.85%	4,588 $350,000
Q4 2019 Jan 15, 2020	SELL	$72.13 - $90.25 $33,540 - $41,966	-465 Reduced 7.94%	5,388 $477,000
Q3 2018 Oct 18, 2018	SELL	$88.91 - $98.84 $171,507 - $190,662	-1,929 Reduced 24.79%	5,853 $554,000
Q2 2018 Jul 20, 2018	SELL	$89.78 - $106.23 $89 - $106	-1 Reduced 0.01%	7,782 $721,000
Q1 2018 Apr 19, 2018	SELL	$92.01 - $123.21 $110,412 - $147,852	-1,200 Reduced 13.36%	7,783 $737,000
Q4 2017 Jan 10, 2018	BUY	$89.56 - $98.21 $125,384 - $137,494	1,400 Added 18.46%	8,983 $869,000
Q3 2017 Oct 20, 2017	BUY	$69.85 - $89.22 $529,672 - $676,555	7,583	7,583 $674,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avity Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avity Investment Management Inc. with notifications on news.

Account

Avity Investment Management Inc. Abb Vie Inc. Transaction History